Figure 3
From: Gramicidin S and melittin: potential anti-viral therapeutic peptides to treat SARS-CoV-2 infection
The anti SARS-CoV2 activity of remdesivir gramicidin S and melittin at 12 (a) and 24 (b) h post infection. The X axis represents different experimental groups: I.C (infection control), remdesivir (1 µM), gramicidin S (3.0 µg), and melittin (1.5 µg). The Y axis (Blue bars) represents % of viral reduction and Y’-Axis (black bars) represents the Log10 viral particles.
